This is a working overview of lyophilised powder, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-12-02. Anything still debated is marked as such rather than presented as settled.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
At moderate to high doses (5–15 g of raw leaves), at which opioid effects generally appear, additional adverse effects include tachycardia (an increased stimulant effect) as well as the opioid side effects of constipation, dizziness, hypotension, dry mouth, and sweating. Long-term use of high doses of kratom may lead to development of tolerance, dependence, and withdrawal symptoms, including loss of appetite, weight loss, decreased libido, insomnia, muscle spasms, muscle and bone pain, increased yawning and/or sneezing, myoclonus, watery eyes, hot flashes, fever, diarrhea, restlessness, anger, and sadness. This may lead to resumption of use. Frequent use of high doses of kratom may cause tremors, anorexia, weight loss, seizures, psychosis and other mental health conditions. Kratom use has a small but statistically significant association with externalizing mental health disorders. Kratom use may worsen existing mental health conditions. In case reports associating kratom use with psychosis, it remains unclear whether kratom use directly caused psychosis or simply unmasked the condition. Serious toxicity is relatively rare and generally appears at high doses or when kratom is used with other substances. Herb–drug interactions may result when kratom is combined with alcohol, sedatives, benzodiazepines, opioids, caffeine, cocaine, yohimbine, or monoamine oxidase inhibitors (MAOIs). Rhabdomyolysis is one of the rare and serious complications of this herb at high dosage.
The United States has an extensive air transportation network. U.S. civilian airlines are all privately owned. The three largest airlines in the world, by total number of passengers carried, are U.S.-based; American Airlines became the global leader after its 2013 merger with US Airways. Of the 50 busiest airports in the world, 16 are in the United States, as well as five of the top 10. The world's busiest airport by passenger volume is Hartsfield–Jackson Atlanta International in Atlanta, Georgia. In 2022, most of the 19,969 U.S. airports were owned and operated by local government authorities, and there are also some private airports. Some 5,193 are designated as "public use", including for general aviation. The Transportation Security Administration (TSA) has provided security at most major airports since 2001. The country's inland waterways are the world's fifth-longest, totaling 25,482 mi (41,009 km). They are used extensively for freight, recreation, and a small amount of passenger traffic. Of the world's 50 busiest container ports, four are located in the United States, with the busiest in the country being the Port of Los Angeles.
== Patents == US patent 3987302, George S. Hurst, Marvin G. Payne, Edward B. Wagner, "Resonance ionization for analytical spectroscopy", issued October 19, 1976 US patent 4,442,354, Hurst, G. Samuel, James E. Parks, James E. & Schmitt, Harold W, "Method of analyzing for a component in a sample", issued April 10, 1984
Melvin Miles was granted in 2004 a patent for a cold fusion device, and in 2007 he described his efforts to remove all instances of "cold fusion" from the patent description to avoid having it rejected outright. At least one patent related to cold fusion has been granted by the European Patent Office. A patent only legally prevents others from using or benefiting from one's invention. However, the general public perceives a patent as a stamp of approval, and a holder of three cold fusion patents said the patents were very valuable and had helped in getting investments.
=== Philippines === The Armed Forces of the Philippines formerly had a combat ration similar to American MREs. Typically, they included a small can of sardines or tuna, instant noodles, crackers, instant coffee, a small packet of peanuts, ginger tea, and a biscuit or cookie. Chocolate manufactured for hot conditions are sometimes issued. Canned rice is also issued. In 2016, "Ready-to-Eat" rations were announced to replace older rations. They are packed in green plastic retort pouches and considered fit to eat for Muslim service members (halal). For example, Menu #2 has four packs of cooked rice, one tuna rice with sisig, one pack of chicken sausage with sauce, one pack of chicken lechon paksiw, one pack of powdered milk, one pack of 3-in-1 coffee, one pack of plain crackers, a spork, and wet tissues.
Sources: en.wikipedia.org
=== October 1880 === The outbreak of the Gun War (also known as Basutoland Rebellion) prompted other tribes to rise up in revolt. In Griqualand East, Charles Brownlee reported that the Basuto clans residing south of Drakensberg had been incited to revolt by the rebels in Basutoland on 4 October. Brownlee initially attempted to quell the uprising through negotiations, however this plan had to be abandoned when the learnt that the rebels were planning to assassinate him and the members of his administration. He then evacuated his district's white population to Kokstad, while the rebels massacred members of the loyalist Hlubi and Bhaca tribes. Members of the Griqua and Mpondomise tribes rose up in the Qumbu and Tsolo Districts. The Qwati and some of the Thembu clans launched their own revolts in Thembuland. While Basuto incitement did play a role, the causes of those rebellions varied. Some tribes feared disarmament, others opposed the continuous erosion of traditional power structures, while others believed that merely by killing the local white population, colonial rule would disappear. The revolts in Transkei lasted until February 1881 and forced the already outnumbered Cape army to divert troops to other fronts. Frere was recalled to Britain and Major General Henry Hugh Clifford, who had temporarily succeeded him, opposed both the war and Sprigg's policies. Under the terms of the responsible government system, the Cape was responsible for its own internal security, with two British regiments being stationed in the region for the War Office's own purposes.
saturation hybridization An in vitro nucleic acid hybridization reaction in which one polynucleotide component (either DNA or RNA) is supplied in great excess relative to the other, causing all complementary sequences in the other polynucleotide to pair with the excess sequences and form hybrid duplex molecules.
== Variants == There is no consensus on some terms describing carbon nanotubes in the scientific literature: both "-wall" and "-walled" are being used in combination with "single", "double", "triple", or "multi", and the letter C is often omitted in the abbreviation, for example, multi-walled carbon nanotube (MWNT). The International Standards Organization typically uses "single-walled carbon nanotube (SWCNT)" or "multi-walled carbon nanotube (MWCNT)" in its documents.
=== 25 July === Russia took the village of Yasnobrodivka in Donetsk Oblast. Russian forces managed to nearly surround two battalions of the Ukrainian 31st Mechanized Brigade near Prohres. Later, according to DeepState, the 31st Mechanized Brigade broke out of the encirclement on the Pokrovsk axis. In Russia, the governor of Belgorod Oblast claimed that one person was killed and two others were injured by Ukrainian shelling in Shebekino. Romanian authorities said that debris from a Russian drone was recovered from the border town of Plauru following an air attack on Izmail. Denmark and the Netherlands pledged to deliver 14 Leopard 2A4 tanks to Ukraine, according to Dutch Defense Minister Ruben Brekelmans. HUR special forces attacked Russian forces at the Kuweires airbase in Syria, destroying an electronic warfare station.
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.